Historical Stock Price
ETFs Holding GILD »    GILD Split History »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
07/12/2019 $66.17 $66.68 $65.89 $66.26 4.74M
07/15/2019 $66.98 $68.25 $66.84 $68.07 7.50M
07/16/2019 $68.07 $68.20 $66.51 $66.94 5.57M
07/17/2019 $67.13 $67.42 $66.81 $66.92 4.86M
07/18/2019 $66.63 $67.60 $66.30 $67.21 4.00M
Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercializes medicines. Co.'s primary areas of focus include HIV/AIDS, liver diseases, hematology/oncology and inflammation/respiratory diseases. Co.'s products include Biktarvy for the treatment of HIV-1 infection in certain patients, Vemlidy® for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease, Yescarta (axicabtagene ciloleucel) for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, and Letairis® (ambrisentan) for the treatment of pulmonary arterial hypertension.
GILD historical stock prices picture
Gilead Sciences (GILD) has the following price history information. Looking back at GILD historical stock prices for the last five trading days, on July 12, 2019, GILD opened at $66.17, traded as high as $66.68 and as low as $65.89, and closed at $66.26. Trading volume was a total of 4.74M shares. On July 15, 2019, GILD opened at $66.98, traded as high as $68.25 and as low as $66.84, and closed at $68.07. Trading volume was a total of 7.50M shares. On July 16, 2019, GILD opened at $68.07, traded as high as $68.20 and as low as $66.51, and closed at $66.94. Trading volume was a total of 5.57M shares. On July 17, 2019, GILD opened at $67.13, traded as high as $67.42 and as low as $66.81, and closed at $66.92. Trading volume was a total of 4.86M shares. On July 18, 2019, GILD opened at $66.63, traded as high as $67.60 and as low as $66.30, and closed at $67.21. Trading volume was a total of 4.00M shares.

GILD Historical Stock Prices By Date:

GILD historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Gilead Sciences shares, starting with a $10,000 purchase of GILD, and working forward through the historical stock price information to today.

Growth of $10,000.00
With Dividends Reinvested

Start date: 07/20/2009
End date: 07/18/2019
Start price/share: $23.99
End price/share: $67.21
Starting shares: 416.84
Ending shares: 467.00
Dividends reinvested/share: $8.75
Total return: 213.87%
Average Annual Total Return: 12.12%
Starting investment: $10,000.00
Ending investment: $31,392.86
Years: 10.00
 
Growth of $10,000.00
Without Dividends Reinvested

Start date: 07/20/2009
End date: 07/18/2019
Start price/share: $23.99
End price/share: $67.21
Dividends collected/share: $8.75
Total return: 216.63%
Average Annual Total Return: 12.22%
Starting investment: $10,000.00
Ending investment: $31,673.98
Years: 10.00
Date Close
07/12/2019$66.26
07/15/2019$68.07
07/16/2019$66.94
07/17/2019$66.92
07/18/2019$67.21
GILD is categorized under the Healthcare sector; below are some other companies in the same sector:

GIVN Historical Stock Prices
GKOS Historical Stock Prices
GLYC Historical Stock Prices
GMED Historical Stock Prices
GNCA Historical Stock Prices
GNMK Historical Stock Prices
GNMX Historical Stock Prices
GNOW Historical Stock Prices
GNVC Historical Stock Prices
GRFS Historical Stock Prices

Also explore: GILD shares outstanding history

GILD Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.